Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report) have received an average recommendation of “Moderate Buy” from the seven analysts that are covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and five have assigned a buy rating […]
Day One Biopharmaceuticals (NASDAQ:DAWN) Sees Unusually-High Trading Volume themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Shares of Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report) were up 10.8% during mid-day trading on Tuesday . The company traded as high as $17.50 and last traded at $17.34. Approximately 386,075 shares changed hands during mid-day trading, a decline of 8% from the average daily volume of 421,641 shares. The stock had […]
Day One Biopharmaceuticals, Inc (NASDAQ:DAWN) to Post Q1 2024 Earnings of ($0 71) Per Share, Capital One Financial Forecasts themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report)’s share price shot up 10.8% during trading on Tuesday . The company traded as high as $17.50 and last traded at $17.34. 386,075 shares changed hands during mid-day trading, a decline of 8% from the average session volume of 421,641 shares. The stock had previously closed […]